Menu
Not yet recruiting NCT07048132

Turkish Version of the Headache Screening Questionnaire

Observational Migraine Tension Type Headache Headache

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Headache Screening Questionare.
Who it may be relevant to
Registry conditions: Migraine, Tension Type Headache, Headache. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Validity and Reliability of the Turkish Version of the Headache Screening Questionnaire

Overview

This multi-center, nationwide study aims to evaluate the validity and reliability of the Turkish version of the Headache Screening Questionnaire (HSQ-TR). The 10-item questionnaire is designed to screen for migraine and tension-type headache in individuals with headache complaints. Participants presenting with headache will be enrolled. Each participant will first complete the HSQ-TR and then be examined by a neurologist who will provide a diagnosis according to the ICHD-3 beta criteria. The questionnaire results will be compared with the neurologist's diagnoses to assess criterion validity, including sensitivity, specificity, and agreement.

Interventions

  • Diagnostic test Headache Screening Questionare
    The Headache Screening Questionnaire (HSQ) is a 10-item tool developed to screen for migraine and tension-type headache (TTH), based on the ICHD-3 beta criteria. Each item reflects a diagnostic criterion for migraine or TTH. Participants complete the HSQ and are also evaluated by a neurologist for diagnosis. A score of 6 or higher suggests "probable migraine" or "probable TTH."

Primary outcome measures

  • ICHD-3 Beta Classification [Time frame: Day 1, Two weeks later control]
  • Headache Screening Questionare [Time frame: Day 1,Two weeks later control]

Eligibility criteria

Inclusion criteria

  • Individuals aged 18 and over who present with headache complaints (migraine or tension-type) and voluntarily agree to participate

Exclusion criteria

  • Individuals with severe psychiatric disorders, illiteracy in Turkish, or significant cognitive impairment preventing comprehension of the scale

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07048132 · B.10.1.TKH.4.34.H.GP.0.01/169

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗